Exactly. We could have a government program to develop nuclear weapons (I wonder if the director of that program made as much as the CEO of Novartis), but we can't have a government program to cure cancer.
There's something wrong with a system where the primary purpose of institutions who fight disease is to make money. Super-valuable research is treated in the same way as making widgets or developing Facebook games -- all that matters is how many dollars it generates for each $100 invested. I find it simultaneously outrageous and ludicrous that the yardstick against which the CEO of Novartis will be judged is how much money the company made, not whether it cured freaking cancer.
There's something wrong with a system where the primary purpose of institutions who fight disease is to make money. Super-valuable research is treated in the same way as making widgets or developing Facebook games -- all that matters is how many dollars it generates for each $100 invested. I find it simultaneously outrageous and ludicrous that the yardstick against which the CEO of Novartis will be judged is how much money the company made, not whether it cured freaking cancer.